ZOLTAN LABORATORIES, LLC

Using Placental Alkaline Phosphatase (PLAP) for
Cancer Cachexia, Bone Marrow (BM) Protection, and Dyslipidemia

Provide recombinant PLAP for (A) cancer patients to prevent muscle wasting and body weight loss (cachexia) as well as therapy induced deterioration of bone marrow function, and (B) obese type 2 diabetic people to normalize high serum lipids (dyslipidemia) and related metabolic conditions.